| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Centre for Cancer Research and Departments of 2 Surgery and 3 Pathology, The University of Hong Kong, Pokfulam, Hong Kong, China and 4 Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland
Requests for reprints: Kwan Man, Department of Surgery, The University of Hong Kong, L9-55, Faculty of Medicine Building, 21 Sassoon Road, Hong Kong, China. Phone: 852-2855-3641; Fax: 852-2819-9634; E-mail: kwanman{at}hkucc.hku.hk or Ronnie T.P. Poon, Department of Surgery, The University of Hong Kong, Hong Kong, China. Phone: 852-2855-3641; Fax: 852-2817-5475; E-mail: poontp{at}hkucc.hku.hk.
Poor prognosis of hepatocellular carcinoma (HCC) is associated with a high potential of vascular invasion and metastasis. Epithelial-mesenchymal transition (EMT) is a key event in the tumor invasion process. Recently, signal transducers and activators of transcription 5 (STAT5) has been linked to tumor progression by EMT induction. However, the precise roles of STAT5 genes (STAT5a and STAT5b) in human epithelial cancers have not been elucidated clearly. The aim of this study is to analyze the roles of STAT5 isoforms in HCC progression using HCC clinical samples. We showed that activation of STAT5b, but not STAT5a, was found in HCC clinical samples and its expression was significantly associated with younger age (P = 0.037), advanced tumor stages (P = 0.003), venous infiltration (P = 0.016), microsatellite formation (P = 0.024), multiple tumor nodules (P = 0.02), and poor patient survival. To specifically investigate the mechanism underlying constitutive activation of STAT5b in HCC, EGFP-HBX was introduced into Huh-7 cells. STAT5b activation in HCC is at least partially mediated by HBX activation. Ectopic STAT5b transfection conferred increased HCC cell motility and invasiveness by induction of EMT changes. In conclusion, STAT5b activation enhanced HCC aggressiveness by induction of EMT, which was possibly mediated by HBX activation. STAT5b could serve as a novel molecular target for HCC treatment. (Cancer Res 2006; 66(20): 9948-56)
This article has been cited by other articles:
|
|
 |
|
  N. MIURA, T. YANO, F. SHOJI, D. KAWANO, T. TAKENAKA, K. ITO, Y. MORODOMI, I. YOSHINO, and Y. MAEHARA Clinicopathological Significance of Sip1-associated Epithelial Mesenchymal Transition in Non-small Cell Lung Cancer Progression Anticancer Res, October 1, 2009; 29(10): 4099 - 4106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-K. Sung, Y. Lu, C. W. H. Lee, D. Zhang, M. Ronaghi, and C. G. L. Lee Deregulated Direct Targets of the Hepatitis B Virus (HBV) Protein, HBx, Identified through Chromatin Immunoprecipitation and Expression Microarray Profiling J. Biol. Chem., August 14, 2009; 284(33): 21941 - 21954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hosui, A. Kimura, D. Yamaji, B.-m. Zhu, R. Na, and L. Hennighausen Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation J. Exp. Med., April 13, 2009; 206(4): 819 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Koppikar, V. W. Y. Lui, D. Man, S. Xi, R. L. Chai, E. Nelson, A. B.J. Tobey, and J. R. Grandis Constitutive Activation of Signal Transducer and Activator of Transcription 5 Contributes to Tumor Growth, Epithelial-Mesenchymal Transition, and Resistance to Epidermal Growth Factor Receptor Targeting Clin. Cancer Res., December 1, 2008; 14(23): 7682 - 7690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-B. Ding, Y.-H. Shi, J. Zhou, S.-J. Qiu, Y. Xu, Z. Dai, G.-M. Shi, X.-Y. Wang, A.-W. Ke, B. Wu, et al. Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma Cancer Res., November 15, 2008; 68(22): 9167 - 9175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hosui and L. Hennighausen Genomic dissection of the cytokine-controlled STAT5 signaling network in liver Physiol Genomics, July 1, 2008; 34(2): 135 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu, L. Wang, S. Zhang, J. Lin, S. Zhang, M. A. Feitelson, H. Gao, and M. Zhu Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses Carcinogenesis, June 1, 2008; 29(6): 1207 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Puppin, D. Fabbro, M. Dima, C. Di Loreto, E. Puxeddu, S. Filetti, D. Russo, and G. Damante High periostin expression correlates with aggressiveness in papillary thyroid carcinomas J. Endocrinol., May 1, 2008; 197(2): 401 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Lee, R. T.P. Poon, J. Y. Wo, S. Ma, X.-Y. Guan, J. N. Myers, P. Altevogt, and A. P.W. Yuen Lupeol Suppresses Cisplatin-Induced Nuclear Factor-{kappa}B Activation in Head and Neck Squamous Cell Carcinoma and Inhibits Local Invasion and Nodal Metastasis in an Orthotopic Nude Mouse Model Cancer Res., September 15, 2007; 67(18): 8800 - 8809. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
